Grant Zeng, CFA
Research analyst, CFA, biotech, small-cap

Galena: Why We Think There Is More Room For Significant Share Price Appreciation

We initiated coverage of Galena Biopharma (NASDAQ:GALE) in mid-November 2011. At that time, the share price of GALE was at about $0.70 per share. As of July 29, 2013, the share price of GALE is $1.77, an appreciation of 153%.

We think the impressive appreciation of share price has been based on many positive developments within the company in the past two years, such as the advancement of the company's clinical programs, expansion of pipeline and boosting of its balance sheet.

After having reaped such an amazing return, the legitimate question investors may ask is: what's next for GALE from here? My answer to this question: there is still enough room for significant price appreciation for GALE in

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details